News

FFAR Funds Veterinary Research to Address Pandemic Diseases

In response to the coronavirus pandemic, the Foundation for Food and Agriculture Research (FFAR) is funding five additional Vet Fellowships to conduct pandemic and zoonotic research. The FFAR Vet Fellows program equips veterinary students with the expertise to address future agricultural challenges.

Up to 75 percent of emerging infectious diseases are zoonotic, meaning a pathogen can spread from animals to humans. Both coronaviruses and influenza viruses can be zoonotic and can be found in agricultural animals such as poultry and pigs. Research on food-animal production and veterinary medicine can reduce the threat of zoonotic pathogens. Yet, veterinary students have limited opportunities to research zoonotic diseases in agriculture.

“The coronavirus is an example of how pathogens can move between humans and animals,” said FFAR’s Executive Director Sally Rockey. “Understanding new diseases in animals, and especially how they spread, is vital to slowing transmission and developing remedies. FFAR is expanding the Vet Fellows to assure we have the expertise in the veterinary community to address what could be future pandemics.”

A recent JAVMA article agrees that veterinarians are needed in the research field to be part of the solution. FFAR is ensuring that the future scientific workforce includes veterinarians with expertise in zoonotic pathogens by funding five additional Vet Fellowships to conduct research on pathogens that threaten agricultural productivity and human health. To bolster the scientific workforce in response to the coronavirus, FFAR is not requiring the 2020 Vet Fellows to secure matching funds. Additionally, FFAR and the Association of American Veterinary Medical Colleges (AAVMC), who partners with FFAR to administer the program, extended the nomination deadline to May 6, 2020.

The FFAR Vet Fellows program will still support ten students to conduct research on agricultural productivity, public health and environmental sustainability. Information about applying for the FFAR Vet Fellows Program is available on FFAR’s website. The fifteen 2020 FFAR Vet Fellows will be announced in summer 2020.

Recent News

05/22/2026

BIO Statement on Veto of Prescription Drug Affordability Boards (PDAB) in VirginiaPatrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia: “BIO applauds Governor Spanberger’s decision to veto SB 271 and HB 483 — legislation that would have established a Prescription Drug Affordability Board (PDAB) and imposed arbitrary price controls in Virginia. The Governor’s action recognized an important point: even well-intentioned healthcare policies must be carefully designed to avoid unintended consequences for patients, providers, employers, and Virginia’s innovation economy. “BIO is proud to represent biotechnology companies developing the next generation of life-changing medicines, including many in the Commonwealth. We believe policymakers play a critically important role in helping advance both patient access to treatments and the continued growth of the life sciences sector. “We look forward to working with the Governor’s Administration, the General Assembly, Virginia Bio and other stakeholders to advance practical, patient-centered policy solutions that improve affordability while preserving access to care and the innovation ecosystem patients depend on.”

Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia: “BIO applauds Governor Spanberger’s decision to veto SB 271 and HB 483 — legislation that would have established a Prescription

05/21/2026

Virginia Bio Applauds Governor Spanberger’s Veto of SB 271 and HB 483

The Virginia Biotechnology Association (Virginia Bio) today expressed strong support for Governor Abigail Spanberger’s decision to veto Senate Bill 271 and House Bill 483, legislation that would have established a Prescription Drug Affordability Advisory Panel (PDAAP) in the Commonwealth. Virginia Bio and the Virginia Chamber of Commerce sent a joint letter to Governor Spanberger commending

05/21/2026

New Global Clinical Society to Bring Focused Ultrasound Into Mainstream Medicine

The Focused Ultrasound Foundation today announced the launch of the International Focused Ultrasound Society (IFUS), a new organization dedicated to advancing clinical practice and accelerating adoption of focused ultrasound – a revolutionary, noninvasive therapeutic technology. Established as a program of the Focused Ultrasound Foundation, IFUS aggregates and expands the Foundation’s activities related to clinical implementation